MedTrace Logo

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

NCT05576103 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-06-18

No results posted yet for this study

Summary

In this proposal, the investigators introduce a novel, translational study to prospectively examine primary brain tumor patients undergoing fractionated radiation therapy to the brain. Quantitative neuroimaging, radiation dose information, and directed neurocognitive testing will be acquired through this study to improve understanding of cognitive changes associated with radiation dosage to non-targeted tissue, and will provide the basis for evidence-based cognitive- sparing brain radiotherapy.

Conditions

Sponsors & Collaborators

  • Jona Hattangadi-Gluth

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05576103 on ClinicalTrials.gov